Quick Take: Entheon Biomedical Corp. announced it has entered into a drug-supply agreement with Psygen Labs Inc. The agreement provides Entheon with DMT drug material for preliminary formulation, stability and testing required prior to its forthcoming human clinical trial, scheduled to begin in Q4 2021 Entheon shareholders have also exercised an aggregate 533,359 warrants at…